Northstar Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,118
Closed -$280K 155
2024
Q4
$280K Sell
2,118
-100
-5% -$13.2K 0.05% 124
2024
Q3
$323K Sell
2,218
-100
-4% -$14.6K 0.06% 120
2024
Q2
$318K Sell
2,318
-653
-22% -$89.6K 0.06% 116
2024
Q1
$408K Hold
2,971
0.08% 100
2023
Q4
$404K Sell
2,971
-98
-3% -$13.3K 0.09% 96
2023
Q3
$375K Sell
3,069
-344
-10% -$42.1K 0.09% 100
2023
Q2
$433K Buy
3,413
+44
+1% +$5.59K 0.1% 93
2023
Q1
$435K Sell
3,369
-200
-6% -$25.8K 0.11% 91
2022
Q4
$469K Sell
3,569
-401
-10% -$52.7K 0.13% 87
2022
Q3
$465K Buy
3,970
+15
+0.4% +$1.76K 0.14% 86
2022
Q2
$465K Sell
3,955
-150
-4% -$17.6K 0.13% 90
2022
Q1
$535K Sell
4,105
-200
-5% -$26.1K 0.13% 93
2021
Q4
$657K Buy
4,305
+100
+2% +$15.3K 0.16% 84
2021
Q3
$680K Hold
4,205
0.18% 83
2021
Q2
$688K Sell
4,205
-200
-5% -$32.7K 0.18% 83
2021
Q1
$663K Buy
4,405
+1
+0% +$151 0.19% 81
2020
Q4
$667K Sell
4,404
-100
-2% -$15.1K 0.2% 78
2020
Q3
$610K Sell
4,504
-99
-2% -$13.4K 0.21% 79
2020
Q2
$629K Sell
4,603
-601
-12% -$82.1K 0.25% 70
2020
Q1
$561K Sell
5,204
-339
-6% -$36.5K 0.26% 70
2019
Q4
$668K Sell
5,543
-400
-7% -$48.2K 0.26% 73
2019
Q3
$591K Sell
5,943
-20
-0.3% -$1.99K 0.25% 73
2019
Q2
$651K Sell
5,963
-1,279
-18% -$140K 0.28% 73
2019
Q1
$810K Buy
7,242
+180
+3% +$20.1K 0.36% 67
2018
Q4
$662K Sell
7,062
-1,321
-16% -$124K 0.34% 66
2018
Q3
$1.02M Sell
8,383
-297
-3% -$36.2K 0.47% 53
2018
Q2
$920K Buy
8,680
+450
+5% +$47.7K 0.47% 56
2018
Q1
$878K Buy
+8,230
New +$878K 0.46% 55